Cargando…

Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis

BACKGROUND: Hepatocellular carcinoma (HCC) is rapidly increasing in the U.S. and is a leading cause of mortality for patients with cirrhosis. Discovering novel biomarkers for risk stratification of HCC is paramount. We examined biomarkers of the gut-liver axis in a prospective multicenter cohort. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Tien S., Jacobs, Jonathan P., Agopian, Vatche, Pisegna, Joseph R., Ayoub, Walid, Durazo, Francisco, Enayati, Pedram, Sundaram, Vinay, Benhammou, Jihane N., Noureddin, Mazen, Choi, Gina, Lagishetty, Venu, Fiehn, Oliver, Goodman, Marc T., Elashoff, David, Hussain, Shehnaz K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287237/ https://www.ncbi.nlm.nih.gov/pubmed/34799768 http://dx.doi.org/10.1007/s10620-021-07299-2

Ejemplares similares

Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
por: Jacobs, Jonathan P., et al.
Publicado: (2018)

Dietary Protein, Fiber and Coffee Are Associated with Small Intestine Microbiome Composition and Diversity in Patients with Liver Cirrhosis
por: Hussain, Shehnaz K., et al.
Publicado: (2020)

Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival
por: Alvarez, Marcus, et al.
Publicado: (2022)

Management of refractory ascites in cirrhosis: Are we out of date?
por: Annamalai, Alagappan, et al.
Publicado: (2016)

Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth?
por: Ashhab, Ashraf A., et al.
Publicado: (2021)

Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience
por: Sheen, Victoria, et al.
Publicado: (2016)

A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD
por: Dong, Tien S., et al.
Publicado: (2020)

Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals
por: Nguyen, Kelvin, et al.
Publicado: (2017)

Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis
por: Bangaru, Saroja, et al.
Publicado: (2020)

The impact of COVID-19 on the cascade of care of HCV in the US and China
por: Yeo, Yee Hui, et al.
Publicado: (2022)

Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
por: Aby, Elizabeth S, et al.
Publicado: (2017)

Autoimmune atrophic gastritis: current perspectives
por: Minalyan, Artem, et al.
Publicado: (2017)

Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge
por: Steggerda, Justin A, et al.
Publicado: (2020)

Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma
por: Benhammou, Jihane N., et al.
Publicado: (2020)

Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort
por: Park, Song-Yi, et al.
Publicado: (2020)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis
por: Noureddin, Mazen, et al.
Publicado: (2023)

Duodenal Permeability Is Associated With Mucosal Microbiota in Compensated Cirrhosis
por: Bloom, P.P., et al.
Publicado: (2022)

Impact of the Share 35 Policy on Perioperative Management and Mortality in Liver Transplantation Recipients
por: Lapisatepun, Warangkana, et al.
Publicado: (2021)

Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma
por: Shaikh, Anjiya, et al.
Publicado: (2022)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
por: Lee, Yi-Te, et al.
Publicado: (2023)

Eosinophilic Ascites and Duodenal Obstruction in a Patient with Liver Cirrhosis
por: Maleki, Nasrollah, et al.
Publicado: (2014)

Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma
por: Benhammou, Jihane N., et al.
Publicado: (2020)

Duodenal Bulb Mucosa with Hypertrophic Gastric Oxyntic Heterotopia in Patients with Zollinger Ellison Syndrome
por: Kohan, Emil, et al.
Publicado: (2009)

Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
por: Dong, Tien S, et al.
Publicado: (2018)

Neurologic Imaging in a Patient with Cirrhosis and Altered Mental Status: To CT or Not to CT
por: Polyak, Alexander, et al.
Publicado: (2021)

Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores
por: Noureddin, Mazen, et al.
Publicado: (2023)

Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018)

Understanding the Heterogeneity of Obesity and the Relationship to the Brain-Gut Axis
por: Hung, Tony K. W., et al.
Publicado: (2020)

Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004–2018 Analysis
por: Noureddin, Nabil, et al.
Publicado: (2020)

Primary Duodenal Aspergillosis in a Patient With Alcoholic Cirrhosis and Poorly Controlled Diabetes Mellitus
por: Gjeorgjievski, Mihajlo, et al.
Publicado: (2016)

Effect of maternal vitamin and mineral restrictions on the body fat content and adipocytokine levels of WNIN rat offspring
por: Lagishetty, Venu, et al.
Publicado: (2007)

Diagnosis and Management of Perforated Duodenal Ulcers following Roux-En-Y Gastric Bypass: A Report of Two Cases and a Review of the Literature
por: Iskandar, Mazen E., et al.
Publicado: (2015)

Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers
por: Ayoub, Walid S., et al.
Publicado: (2019)

Hepatitis Delta: Epidemiology, Diagnosis and Management 36 Years After Discovery
por: Noureddin, Mazen, et al.
Publicado: (2013)

Current and Potential Therapies Targeting Inflammation in NASH
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?
por: Noureddin, Nabil, et al.
Publicado: (2020)

Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2023)

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
por: Aby, Elizabeth, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_05nmqmf4v4ik2j54a9vd766m6h